Participating Faculty

August 1, 2005
Supplements and Featured Publications, Emerging Issues in the Treatment of Acute Otitis Media: Implications for Managed Care, Volume 11, Issue 6 Suppl

The American Journal of Managed Care

This supplement to contains information on otitis media and its impact on managed care.


Diana I. Brixner, RPh, PhD

Department of Pharmacotherapy

Pharmacotherapy Outcomes Research Center

Professor, Microbiology and Immunology, Pediatrics and Medicine

Rochester, New York

Disclosure Statement

The American Journal of Managed Care

It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

These participants report relationships with the following pharmaceutical companies:

Diana I. Brixner, RPh, PhD

Grant/Research Support From:

  • Aventis
  • Boehringer-Ingelheim
  • Genzyme
  • TAP

Speaker or Consultant To:

  • Amgen
  • Bristol-Myers Squibb
  • NPS
  • TAP

Michael E. Pichichero, MD

Grant/Research Support From:

  • Abbott
  • Eli Lilly
  • Johnson & Johnson
  • Sanofi-Aventis

CME Speaker For or Ad Hoc Consultant To:

  • Bristol-Myers Squibb
  • GlaxoSmithKline
  • Sanofi-Aventis

The American Journal of Managed Care,

Signed disclosures are on file at the offices of Jamesburg, New Jersey.

This program is supported by an educational grant from Abbott.

The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.